Glaxo (GSK), SK bioscience’s COVID-19 Jab Enters Phase III Study

Posted byZacks Equity Research Leave a comment on Glaxo (GSK), SK bioscience’s COVID-19 Jab Enters Phase III Study

GlaxoSmithKline (GSK) and SK bioscience begin a phase III study on GBP510, the latter’s COVID-19 vaccine candidate. The study will compare GBP510 agai…

Leave a comment

Your email address will not be published. Required fields are marked *